Posts

Psychedelic Business Spotlight – June 3

,
This week in psychedelic business news: Cybin moves towards clinical trials; Braxia releases data on treating depression with psilocybin; Clearmind files for a new patent; and much more!
British Columbia to Decriminalize Possession of All Drugs

British Columbia to Decriminalize Possession of Most Drugs

Those caught with under 2.5 grams of illicit drugs, including heroin and fentanyl, will not face jail time when the regulations go into effect.
Psilocybin Study Links Psychedelics to Lower Risk of Opioid AddictionShutterstock

New Study Links Psilocybin to Lower Risk of Opioid Addiction

Researchers attempt to replicate findings from a 2017 study that found classic psychedelic use conferred reduced risk of past-year opioid dependence and abuse.
Spotlight in Focus: Opioid Crisis Demands Psychedelic Innovation, Yesterday

Spotlight in Focus: Opioid Crisis Demands Psychedelic Innovation, Yesterday

This month's "Spotlight in Focus" features candid conversation with an opioid addict, and the director writes how psychedelic therapy can help.
4 Ways Psychedelics Can Positively Transform Women's Mental Health

4 Ways Psychedelics Can Positively Transform Women’s Mental Health

Jessika Lagarde, the co-founder of Women on Psychedelics, explores how various psychoactive substances can treat mental health issues including depression, eating disorders, PTSD, and addiction.
Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction

Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction

“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other substances combined, making this research vital," says Mydecine Innovations...
Awakn Life Science CEO Anthony Tennyson "Groundbreaking" MDMA discovery

Awakn Life Sciences CEO Details ‘Groundbreaking’ MDMA Discovery in Quest to Treat Addiction

, ,
Anthony Tennyson tells the Psychedelic Spotlight Podcast that his company has "discovered receptor sites that MDMA interacts with that we believe nobody else in the world knows about."

Lamar Odom Documentary About His Recovery Through Psychedelics Makes Its Debut

Former NBA star Lamar Odom details his recovery from substance abuse with the aid of psychedelic medicine in a new documentary.
Awakn Life Sciences Psychedelics

U.K. Psychedelic R&D Company Investigates MDMA, Ketamine for Addiction

Awakn Life Sciences is looking at psychedelics for addiction, namely MDMA and ketamine for alcohol use disorder.
So, You Want to Take Ibogaine: Here's What You Need to Know About Treatment

So, You Want to Take Ibogaine: Here’s What You Need to Know About Treatment

Ibogaine treatment can help with a number of conditions including addiction. But where should you go? Are all centers safe? Here's what you need to know.